Physician Compensation Embraces Satisfaction, Quality Metrics
Marisa Torrieri, October 22, 2013
The latest physician compensation survey from ECG Management Consultants highlights increasing emphasis on value, quality of care.
How Physicians Can Manage Unexpected Free Time
Jennifer Frank, MD, October 22, 2013
Whether you have an unexpected patient no-show, or two hours before bed, figuring out how to spend spurts of free time can be a work-life balance stressor.
Basic Technology Marketing Moves Physicians Must Implement
Ike Devji, JD, October 22, 2013
Many medical practices continue to overlook technology marketing basics, a fatal mistake in an era of increased competition and decreasing reimbursement.
The Impact of Income Inequality on Out-of-Pocket Healthcare Costs
Leann DiDomenico McAllister, October 21, 2013
A recent interaction with a patient over who should and shouldn't pay copays due to income got me thinking about how income equality affects healthcare costs.
EHR Progress Has Been Stymied By Not Seeing the Whole Board
Daniel Essin, MA, MD, October 21, 2013
EHR, like international relations and war, presents many facets, each of which provides a "box" of sorts that can confine thought in unique ways.
Physical Activity Lowers Crohn’s Risk in Woman, But Not Ulcerative Colitis
November 25, 2013
Exercise may affect the immune responses that determine which digestive diseases is likely to affect susceptible females.
Two Therapies Beat One in Pancreatic Cancer
November 21, 2013
Neoadjuvant stereotactic body radiotherapy offers impressive survival rates for pancreatic cancer, and a combination of taxanes improves chemotherapy results.
How to Avoid ADHD Overdiagnosis
November 20, 2013
A plea for great care in diagnosing attention deficit hyperactivity disorder, and evidence that ADHD persisting to adulthood often requires continued medication.
Pneumococcal Pneumonia Serotypes Inform Vaccinations
November 19, 2013
Typing of pneumococcal strains gives insights into severity and transmission patterns of community-acquired pneumonia.
The Pro and Con of Rituximab in CLL
November 14, 2013
Rituximab achieves prolonged progression-free survival for patients with chronic lymphocytic leukemia, but it boosts the risk of hepatitis B recurrence.